Polar Asset Management Partners’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Polar Asset Management Partners’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-479,504	Closed	-$1.06M	–	1041
2023 Q2	$1.06M	Buy	+479,504	New	+$994K	0.02%	512

Polar Asset Management Partners's PRTK Position: Q3 2023 in Review

Polar Asset Management Partners sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 479,504 shares — an estimated $1.06M sold.

Polar Asset Management Partners first reported a position in PRTK in Q2 2023 and held it in 1 quarter. The position peaked at $1.06M in Q2 2023. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

Polar Asset Management Partners reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Polar Asset Management Partners sold 479,504 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $1.06M.
Polar Asset Management Partners first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2023 and held it in 1 quarter.
Polar Asset Management Partners's Paratek Pharmaceuticals, Inc. position peaked at $1.06M in Q2 2023.
0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Polar Asset Management Partners's 13F filing for Q3 2023, filed 14 Nov 2023.